Quorum Health Corporation QHC reported second-quarter 2016 adjusted loss of $1.02 per share, comparing unfavorably with the Zacks Consensus Estimate of earnings of 11 cents. The company had reported earnings of 5 cents per share in the year-ago quarter. The loss per share figure excludes impairment charges of $216.1 million or $7.61 per share.
On Apr 29, Quorum Health became an independent public company post its spin off from Community Health Systems CYH. The company includes 38 affiliated hospitals and related outpatient services in 16 states.
Quarter Details
Total net operating revenues declined 1.6% year over year to $529.7 million. Number of licensed beds at end of period declined 0.4% to 3.579. Adjusted admissions were 58,942, down 2.5% from the year-ago quarter.
However, total operating costs and expenses climbed 4.1% from the year-ago quarter to almost $532 million, led by a 4.4% year-over-year rise in salaries and benefits amounting to $264.9 million.
Notably, operating results excludes $250.4 million of impairment charges, $1.2 million of transaction costs related to the spin-off and $5.4 million of legal and settlement costs.
Adjusted EBITDA in the second quarter was $29.2 million, representing a 51% decline from the year-earlier quarter's $59.6 million.
Guidance
For full-year 2016, Quorum Health anticipates net operating revenues in the range of $2.2 billion to $2.2 billion.
Adjusted EBITDA is estimated in the band of $175 million to $200 million.
Some notable companies in the broader medical sector include Natus Medical Inc. BABY and Masimo Corporation MASI.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
MASIMO CORP MASI: Free Stock Analysis Report
NATUS MEDICAL BABY: Free Stock Analysis Report
COMMNTY HLTH SY CYH: Free Stock Analysis Report
QUORUM HEALTH (QHC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.